Psychedelic Stock IPO the Next 1,000% Gain?

Psychedelic stocks are quickly emerging as a red-hot sector.

Need evidence?

Take a look at Mind Medicine (NASDAQ: MNMD), a promising young biotech headquartered in New York, New York, that specializes in developing psychedelic drug therapies.

Shares were just uplisted from over-the-counter (OTC) markets to the NASDAQ stock exchange, and this stock is now up more than 1,000% in the last nine months. Continue reading “Psychedelic Stock IPO the Next 1,000% Gain?”

Is This a Good Time to Buy Cannabis Stocks?

When the Democrats swept the U.S. elections in November, cannabis investors were excited over the potential for major cannabis reform. Today, 90 days into the Biden administration, we have a much better idea of what to expect.

While it looks like reforms may fall short of the holy grail of ‘federal legalization,’ I see a high probability of game-changing cannabis reform in 2021. Continue reading “Is This a Good Time to Buy Cannabis Stocks?”

Play Michigan’s $1 Billion Cannabis Market with This Industry Leader

Michigan has quickly evolved into one of the largest cannabis markets in the United States after going legal in 2020. Recent sales data shows that Michigan is on pace to generate more than $1 billion in cannabis sales in 2021. That would make Michigan one of the largest cannabis markets in the U.S. Continue reading “Play Michigan’s $1 Billion Cannabis Market with This Industry Leader”

2 Earnings-Beating Cannabis Stocks Ready to Move

It’s one of Wall Street’s best-kept secrets – a studied market anomaly that helps investors ride a move after a company reports an earnings surprise. And right now looks like a great time to apply this strategy to the cannabis sector after two of the most exciting cannabis stocks just crushed fourth-quarter expectations.

I’m talking about post-earnings announcement drift (PEAD) – the tendency for stocks that beat earnings expectations to deliver outsized returns in the following weeks and months. Continue reading “2 Earnings-Beating Cannabis Stocks Ready to Move”

Cannabis Stocks on Sale after 20% Decline

For investors who love getting a good deal, this is an excellent time to take a fresh look at cannabis stocks.

After an incredible 12-month run higher from March of 2020 to February of 2021, cannabis stocks have entered a bear market – defined as a 20% or more decline from the 52-week high.

The Advisors Shares Pure U.S. Cannabis ETF (MSOS) is down 21% from the 52-week high in mid-February. Take a look at the 6-month chart below – you can see the all-time high from February and the recent decline. Continue reading “Cannabis Stocks on Sale after 20% Decline”

Here’s How to Play New York’s Legalization of Recreational Cannabis

New York Governor Andrew Cuomo just revealed that the empire state is close to legalizing recreational cannabis. Analysts were expecting New York to go legal in 2021 – but after Cuomo’s revelations, it looks like it’s going to happen sooner than expected. Continue reading “Here’s How to Play New York’s Legalization of Recreational Cannabis”

This Could Be the Next Big Cannabis Buyout Target

When a stock jumps 47% in one day it is time to start paying attention.

That’s what happened to GW Pharmaceutical (NASDAQ: GWPH), one of the largest cannabis biotechs in the world, on February 3, when news broke that GW was being bought by leading pharma company Jazz Pharmaceutical (NASDAQ: JAZZ).

The news sent shares of GW soaring 47% in one day and into a new all-time high. Continue reading “This Could Be the Next Big Cannabis Buyout Target”

Virginia is Going Legal – Here’s How to Play It

Virginia just voted to legalize recreational cannabis, making it the first southern state to go legal. This is another big step forward for the U.S. cannabis industry and another big win for cannabis investors.

I’m going to reveal one company, valued at $1 billion and growing quickly, that could be the best investment play on Virginia’s big legalization move. Continue reading “Virginia is Going Legal – Here’s How to Play It”